Finward Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Hold
3,695
0.16% 103
2026
Q1
$224K Buy
+3,695
New +$215K 0.18% 98
2025
Q2
Sell
-3,695
Closed -$225K 102
2025
Q1
$225K Sell
3,695
-169
-4% -$9.85K 0.2% 94
2024
Q4
$219K Buy
+3,864
New +$216K 0.19% 93

Other funds holding BMY

Finward Bancorp's BMY Position: Q2 2026 in Review

Finward Bancorp held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,695 shares worth $213K. The position accounts for 0.16% of the portfolio, ranked #103.

Finward Bancorp first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. The position peaked at $225K in Q1 2025. 566 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Finward Bancorp held 3,695 shares of Bristol-Myers Squibb worth $213K as of Q2 2026.
  • Finward Bancorp left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.16% of Finward Bancorp's portfolio in Q2 2026, its #103 holding.
  • Finward Bancorp first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
  • Finward Bancorp's Bristol-Myers Squibb position peaked at $225K in Q1 2025.
  • 566 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Finward Bancorp's 13F filing for Q2 2026, filed 16 Jul 2026.